Cutting edge: increased NK cell activity in HIV-1-exposed but uninfected Vietnamese intravascular drug users.
about
The CD85j+ NK cell subset potently controls HIV-1 replication in autologous dendritic cellsThe role of NK cells in HIV-1 protection: autologous, allogeneic or both?Human NK Cell Diversity in Viral Infection: Ramifications of RamificationEvasion from NK cell-mediated immune responses by HIV-1In vivo assessment of natural killer cell responses during chronic feline immunodeficiency virus infectionNatural killer cells promote early CD8 T cell responses against cytomegalovirusHypercytotoxicity and rapid loss of NKp44+ innate lymphoid cells during acute SIV infectionReduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central AfricansInsufficient natural killer cell responses against retroviruses: how to improve NK cell killing of retrovirus-infected cellsIL-21 enhances NK cell functions and survival in healthy and HIV-infected patients with minimal stimulation of viral replicationImmune responses during spontaneous control of HIV and AIDS: what is the hope for a cure?Antigen-presenting cells represent targets for R5 HIV-1 infection in the first trimester pregnancy uterine mucosa.Induction of Potent and Long-Lived Antibody and Cellular Immune Responses in the Genitorectal Mucosa Could be the Critical Determinant of HIV Vaccine Efficacy.Higher Expression of Activating Receptors on Cytotoxic NK Cells is Associated with Early Control on HIV-1C Multiplication.Acute mucosal pathogenesis of feline immunodeficiency virus is independent of viral dose in vaginally infected cats.Cutting Edge: Unusual NK cell responses to HIV-1 peptides are associated with protection against maternal-infant transmission of HIV-1.Immune reconstitution of CD56(dim) NK cells in individuals with primary HIV-1 infection treated with interleukin-2.Low CD4+ T cell counts among African HIV-1 infected subjects with group B KIR haplotypes in the absence of specific inhibitory KIR ligands.Loss of NK stimulatory capacity by plasmacytoid and monocyte-derived DC but not myeloid DC in HIV-1 infected patients.HIV-1 Vpu antagonism of tetherin inhibits antibody-dependent cellular cytotoxic responses by natural killer cells.NK cytotoxicity against CD4+ T cells during HIV-1 infection: a gp41 peptide induces the expression of an NKp44 ligandMucosal correlates of protection in HIV-1-exposed sero-negative persons.Increased levels of human beta-defensins mRNA in sexually HIV-1 exposed but uninfected individualsAccessory cell dependent NK cell mediated PBMC IFN-gamma production is defective in HIV infection.Alterations of natural killer cell and T-lymphocyte counts in adults infected with human immunodeficiency virus through blood and plasma sold in the past in China and in whom infection has progressed slowly over a long period.Human liver transplantation as a model to study hepatitis C virus pathogenesisInnate immunity against HIV: a priority target for HIV prevention researchIncreased natural killer cell cytotoxicity and NKp30 expression protects against hepatitis C virus infection in high-risk individuals and inhibits replication in vitro.Influence of cytokines on HIV-specific antibody-dependent cellular cytotoxicity activation profile of natural killer cells.Differential association of gene content polymorphisms of killer cell immunoglobulin-like receptors with placental malaria in HIV- and HIV+ mothersTime to seroconversion in HIV-exposed subjects carrying protective versus non protective KIR3DS1/L1 and HLA-B genotypes.Natural killer cell function is well preserved in asymptomatic human immunodeficiency virus type 2 (HIV-2) infection but similar to that of HIV-1 infection when CD4 T-cell counts fall.Living in a house of cards: re-evaluating CD8+ T-cell immune correlates against HIVSimian immunodeficiency virus (SIV)/immunoglobulin G immune complexes in SIV-infected macaques block detection of CD16 but not cytolytic activity of natural killer cellsGenetic and Immunological Factors Involved in Natural Resistance to HIV-1 Infection.Innate activation of MDC and NK cells in high-risk HIV-1-exposed seronegative IV-drug users who share needles when compared with low-risk nonsharing IV-drug user controls.Persistent resistance to HIV-1 infection in CD4 T cells from exposed uninfected Vietnamese individuals is mediated by entry and post-entry blocks.Natural killer cell and T-cell subset distributions and activation influence susceptibility to perinatal HIV-1 infection.Determinants of protection among HIV‐exposed seronegative persons: an overview.Increased plasmacytoid dendritic cell maturation and natural killer cell activation in HIV-1 exposed, uninfected intravenous drug users
P2860
Q21144323-5A613ADD-F18C-4D1C-8BB0-085167D85159Q26753146-31FFED6A-9DA6-4C7D-B268-01BBFD2E1351Q26765925-F31895A5-F360-4D51-9B64-D4EC60B61B26Q26864489-9FBE7659-B588-4C7D-B273-6611C989B98BQ27302300-88F0B742-C4EC-4452-87F0-4949E900AB26Q27319836-71CE9DAA-EE3A-417D-9B03-FABFB0081183Q27322468-A7C4AC9E-8FEB-43A3-BF30-41A76A93519FQ27473420-8A7E8F51-EE5F-4700-A463-4551FC35BB1CQ28068375-8AE33204-BE19-4CFB-BFDA-A3DBE388F647Q28271479-056B6B98-8CDB-4C2E-8B01-5E516162B38DQ30362489-5FE64CF4-7608-4F61-BE43-E3EF9BEEF9B5Q33471468-36695AA2-CC7D-4D6E-979C-3652D6D7E724Q33611645-FBB83F81-1686-4FBE-BFC7-195697F4E79EQ33657935-035D3FD7-07ED-43A8-B751-0955B9FB94D0Q33715758-6F4830BB-C4E4-4EB8-8C09-9DA2A8DE5EC6Q33739243-C3C884EC-5A0C-41B6-91DC-48DD883839B2Q33772422-00F8DA69-0525-4D28-AB63-3FA7C96FE273Q33828392-02141109-C132-4322-B16D-75CA8D2473E9Q33847612-B9BC3376-14C9-474D-A479-FC0F3D888024Q33887674-25E7AC63-6D98-4F35-9C1C-CEC42226EA63Q33906133-404E27C4-1C3D-4FC1-ADF6-9ED926D58864Q33911540-61001D4E-3807-4330-A85A-75BBD13266CAQ34020111-B97213B7-5EC6-4DB0-9E07-97A6E23BE178Q34020126-5304AA6E-4750-45E8-9692-5BE2932162ACQ34143509-924D46CE-BACD-4B5D-BEB3-ED96D53D12A1Q34197528-F73E1D5C-CB77-4603-8B55-5AE1CFA4AD25Q34243462-94C22100-8606-4289-BD30-3379FC844078Q34259130-8AC7D19A-F6EF-435A-B608-55638B23BBD1Q34305570-EBB8CEB1-6C53-4402-9516-031AC77430A5Q34310322-0FB392F0-E5F5-4C60-8F07-11CEE1C1AAD1Q34362162-A562A34B-129F-409B-92A3-02C66C52D419Q34434825-703DF5CD-EF37-40EB-9DF9-933B7504627BQ34514374-D6CF1BE7-1C41-4187-AC74-1551ED2A2EA2Q34720432-6E942B04-D75E-40BC-8FA6-1C93540AC4E7Q35030053-BD78AB9A-4552-46F7-BE83-FD44CF4947B6Q35085106-ED4F32ED-C0F0-4F99-8E94-49BD6EC64A13Q35131130-25545B18-23C8-41DA-9365-059C254E1EEEQ35195360-C894724B-688D-44E1-9CD5-0B6A689347C3Q35252566-47C65E9C-59D6-47FF-A60E-54B6EDAC9DB1Q35660526-00F18682-E79B-48F6-BC0F-F278357B32B8
P2860
Cutting edge: increased NK cell activity in HIV-1-exposed but uninfected Vietnamese intravascular drug users.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Cutting edge: increased NK cel ...... mese intravascular drug users.
@en
type
label
Cutting edge: increased NK cel ...... mese intravascular drug users.
@en
prefLabel
Cutting edge: increased NK cel ...... mese intravascular drug users.
@en
P2093
P50
P1476
Cutting edge: increased NK cel ...... mese intravascular drug users.
@en
P2093
Annie David
Ioannis Theodorou
Lien X Truong
Ngai V Nguyen
Tram T Luong
P304
P356
10.4049/JIMMUNOL.171.11.5663
P407
P577
2003-12-01T00:00:00Z